Trade Akoya Biosciences, Inc. - AKYA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.38 |
| Open | 1.4 |
| 1-Year Change | -70.02% |
| Day's Range | 1.32 - 1.44 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.38 | 0.02 | 1.47% | 1.36 | 1.40 | 1.30 |
| Mar 28, 2025 | 1.40 | -0.05 | -3.45% | 1.45 | 1.45 | 1.36 |
| Mar 27, 2025 | 1.46 | 0.06 | 4.29% | 1.40 | 1.49 | 1.40 |
| Mar 26, 2025 | 1.43 | -0.07 | -4.67% | 1.50 | 1.54 | 1.41 |
| Mar 25, 2025 | 1.52 | -0.09 | -5.59% | 1.61 | 1.66 | 1.50 |
| Mar 24, 2025 | 1.64 | -0.04 | -2.38% | 1.68 | 1.76 | 1.64 |
| Mar 21, 2025 | 1.67 | 0.04 | 2.45% | 1.63 | 1.72 | 1.62 |
| Mar 20, 2025 | 1.66 | 0.07 | 4.40% | 1.59 | 1.72 | 1.59 |
| Mar 19, 2025 | 1.67 | 0.08 | 5.03% | 1.59 | 1.71 | 1.55 |
| Mar 18, 2025 | 1.59 | 0.09 | 6.00% | 1.50 | 1.59 | 1.37 |
| Mar 17, 2025 | 1.53 | 0.04 | 2.68% | 1.49 | 1.58 | 1.49 |
| Mar 14, 2025 | 1.48 | 0.00 | 0.00% | 1.48 | 1.50 | 1.46 |
| Mar 13, 2025 | 1.46 | -0.08 | -5.19% | 1.54 | 1.54 | 1.46 |
| Mar 12, 2025 | 1.54 | -0.07 | -4.35% | 1.61 | 1.62 | 1.54 |
| Mar 11, 2025 | 1.61 | 0.08 | 5.23% | 1.53 | 1.66 | 1.52 |
| Mar 10, 2025 | 1.51 | 0.00 | 0.00% | 1.51 | 1.54 | 1.49 |
| Mar 7, 2025 | 1.57 | 0.08 | 5.37% | 1.49 | 1.57 | 1.49 |
| Mar 6, 2025 | 1.54 | -0.02 | -1.28% | 1.56 | 1.61 | 1.52 |
| Mar 5, 2025 | 1.58 | 0.02 | 1.28% | 1.56 | 1.66 | 1.54 |
| Mar 4, 2025 | 1.61 | 0.20 | 14.18% | 1.41 | 1.61 | 1.41 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Akoya Biosciences, Inc. Company profile
About Akoya Biosciences Inc
Akoya Biosciences, Inc. is a life sciences technology company. The Company deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. It offers contract research services laboratory, which is called as advanced biopharma solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Akoya Biosciences Inc revenues increased 29% to $54.9M. Net loss applicable to common stockholders increased from $21.8M to $44.4M. Revenues reflect Consumables segment increase of 68% to $14.3M, Instruments segment increase of 21% to $28.7M, North America segment increase of 39% to $28M, EMEA segment increase of 21% to $14.4M. Higher net loss reflects Selling.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
100 Campus Drive
6th Floor
MARLBOROUGH
MASSACHUSETTS 01762
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com